Aggressive B-cell lymphomas in patients with myelofibrosis receiving JAK1/2 inhibitor therapyEdit Porpaczy, Veronika Sexl, Sabrina Tripolt et al.|Blood|2018Cited by 155
Incidence of intensive care unit admission, outcome and post intensive care survival in patients with diffuse large B-cell lymphomaPhilipp Wohlfarth, Werner Rabitsch, Andja Bojic et al.|Leukemia & lymphoma/Leukemia and lymphoma|2016Cited by 32
Lupus anticoagulant and thrombosis in splenic marginal zone lymphomaJohanna Gebhart, Katharina Geißler, Klaus Lechner et al.|Thrombosis Research|2014Cited by 25